AIS 2021 - Protecting epitope versus paratope: Case study from Amgen PCSK9

Raphaëlle Gillet and Nicolas Bouquin will discuss the latest decisions regarding antibody patents and in particular the Amgen PCSK9 case at AIS 2021, on June 23rd 2021 at 2PM.

Check the AIS complete programme

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.